Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier

Recently, immune checkpoint inhibitors (ICIs) therapy has become a promising therapeutic strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects. Though, tumor inherent or acquired resistance to ICIs accompanied with treatment-related toxicities hamper their clinical u...

Descripción completa

Detalles Bibliográficos
Autores principales: Vafaei, Somayeh, Zekiy, Angelina O., Khanamir, Ramadhan Ado, Zaman, Burhan Abdullah, Ghayourvahdat, Arman, Azimizonuzi, Hannaneh, Zamani, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725311/
https://www.ncbi.nlm.nih.gov/pubmed/34980128
http://dx.doi.org/10.1186/s12935-021-02407-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725311/
https://www.ncbi.nlm.nih.gov/pubmed/34980128
http://dx.doi.org/10.1186/s12935-021-02407-8

Ejemplares similares